Earth Life Sciences Inc. (CLTS)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Earth Life Sciences Inc. (CLTS) trades at $0.00 with AI Score 48/100 (Grade C). Earth Life Sciences Inc. Market cap: $99,989, Sector: Technology.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for CLTS: CLTS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CLTS against Technology peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CLTS: the 1 perspectives are evenly split.
How is this calculated? →Earth Life Sciences Inc. (CLTS) Technology Profile & Competitive Position
Earth Life Sciences Inc. operates in the transportation software sector, developing solutions for logistics and mobility. Concurrently, it manages a specialized digital platform facilitating online ordering and connecting users with offline health services, primarily serving the North American market from its Reno, Nevada headquarters.
What Is the Investment Thesis for CLTS?
Earth Life Sciences Inc. presents a unique profile as an early-stage technology company operating in two distinct, yet potentially synergistic, market segments: transportation software and digital health services. The investment thesis centers on the long-term growth potential within these sectors, driven by ongoing digitization and demand for integrated solutions. The transportation software market continues to expand with increasing needs for logistics optimization and smart mobility, offering a foundational growth avenue. Simultaneously, the digital health sector is experiencing robust growth, fueled by consumer demand for convenient online access to healthcare services and efficient matching with offline providers. Earth Life Sciences Inc.'s specialized digital platform, designed for online ordering and health service matching, positions it to potentially capture a share of this expanding market. Key value drivers include the scalability of its software platforms, the potential for recurring revenue models from both segments, and the ability to effectively penetrate its primary North American market. However, the company's current operational scale, indicated by its single employee and 100K market capitalization, introduces significant execution risk. Future growth catalysts would likely involve successful product development, strategic partnerships to expand market reach, and securing additional capital for scaling operations.
Based on FMP financials and quantitative analysis
CLTS Key Highlights
- Market capitalization of 100K, reflecting its early-stage or minimal operational footprint within the public market.
- Beta of -55.88, indicating highly unusual and volatile price movements, potentially due to extremely low trading volume or specific market dynamics.
- Operates with a lean structure, reporting 1 employee, suggesting a foundational development stage or reliance on external resources.
- No dividend yield, consistent with a growth-oriented or pre-profitability stage company focused on reinvesting any potential earnings.
- Headquartered in Reno, Nevada, with primary business operations concentrated across the North American market.
Who Are CLTS's Competitors?
CLTS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| IAIC Information Analysis Incorporated | $4.28 | +12.34% | $81.86M | 66 |
| DVLT Datavault AI Inc. | $0.38 | -1.22% | $107.35M | 65 |
| NYAX Nayax Ltd. | $71.97 | +2.49% | $2.63B | 62 |
| TSYHF TravelSky Technology Limited | $1.03 | -2.81% | $3.03B | 60 |
| CCRC China Customer Relations Centers, Inc. | $6.50 | +0.31% | 51 | |
| SYKE Sykes Enterprises, Incorporated | $54.00 | +0.00% | 52 | |
| FISV Fiserv, Inc. | $51.94 | -0.74% | $27.70B | 52 |
| WIZEY Wise plc | $14.49 | +0.00% | $14.49B | 52 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CLTS's Key Strengths?
- Involvement in two high-growth sectors: transportation software and digital health.
- Specialized digital platform for online ordering and health service matching.
- Lean operational structure, potentially allowing for agility and low overhead.
- North American market focus, a large and technologically advanced region.
What Are CLTS's Weaknesses?
- Extremely small operational scale with only 1 employee.
- 100K market capitalization, indicating minimal market presence or early development stage.
- Unknown disclosure status on the OTC market, limiting transparency for investors.
- High beta of -55.88, suggesting extreme volatility or illiquidity.
What Could Drive CLTS Stock Higher?
- Successful launch of an enhanced feature set for its transportation software platform.
- Announcement of a strategic partnership with a logistics provider or healthcare network in North America.
- Public release of a detailed operational update or financial report, improving disclosure.
- Continued development and refinement of its specialized digital platform for health services.
What Are the Key Risks for CLTS?
- Financial-distress signal — its Altman Z-Score of -6.28 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-82.2%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Inability to secure additional funding necessary for scaling operations and product development.
- Intense competition from well-established companies in both the transportation software and digital health sectors.
- Execution risk associated with managing and growing two distinct technology platforms with a minimal employee base.
- Regulatory changes in the healthcare or transportation industries that could impact platform compliance or market viability.
- Challenges in attracting and retaining skilled talent required for advanced software development and market expansion.
What Are the Growth Opportunities for CLTS?
- Deepening Penetration in Transportation Software: The transportation software market continues to expand, driven by the increasing complexity of global supply chains and the need for optimized logistics. Earth Life Sciences Inc. has an opportunity to enhance its existing software solutions, potentially incorporating advanced analytics, AI-driven route optimization, or IoT integration for real-time fleet management. By focusing on specific niches within North America, such as last-mile delivery or specialized freight, the company could capture a larger market share. The global transportation management system market is projected to reach over $20 billion by 2027, indicating substantial room for growth for specialized providers.
- Expanding Digital Health Service Offerings: The digital health market is experiencing robust growth, with consumers increasingly seeking convenient online access to healthcare. Earth Life Sciences Inc.'s platform for online ordering and connecting users with offline health services could expand its offerings to include a wider range of health services, telehealth integration, or personalized health management tools. This could involve partnerships with more healthcare providers or expanding the types of health services available through the platform. The global digital health market is anticipated to exceed $660 billion by 2027, presenting a significant addressable market for innovative platforms.
- Strategic Partnerships and Integrations: Given its lean operational structure, Earth Life Sciences Inc. could accelerate its market penetration and product development through strategic partnerships. Collaborations with established logistics companies could integrate its transportation software directly into larger operational frameworks, while alliances with healthcare networks or insurance providers could significantly expand the reach and utility of its digital health platform. Such partnerships could provide access to larger customer bases, enhance credibility, and facilitate cross-promotion, reducing the need for extensive in-house sales and marketing efforts.
- Leveraging Data for Platform Enhancement: Both the transportation software and digital health platforms generate valuable data regarding user behavior, service demand, and operational efficiencies. Earth Life Sciences Inc. has the opportunity to implement advanced data analytics and machine learning algorithms to derive insights from this data. This could lead to more personalized user experiences on the health platform, more efficient routing algorithms in transportation software, or predictive maintenance features. Continuous data-driven improvement can enhance product stickiness, optimize resource allocation, and create a stronger competitive advantage over time.
- Targeted Geographic Expansion within North America: While the company primarily operates in North America, there is significant potential for deeper penetration into specific regional markets or underserved areas within the continent. This could involve tailoring its platforms to meet the unique regulatory or market demands of different states or provinces, or focusing on specific demographic segments that are early adopters of digital solutions. A phased, targeted expansion strategy, backed by localized marketing and support, could allow Earth Life Sciences Inc. to efficiently grow its user base and client portfolio without overextending its resources.
What Opportunities Does CLTS Have?
- Expansion of its transportation software offerings to new sub-segments or features.
- Growth in demand for digital health services and online access to care.
- Strategic partnerships with larger industry players to accelerate market penetration.
- Leveraging data analytics to enhance platform capabilities and user experience.
What Threats Does CLTS Face?
- Intense competition from established players and well-funded startups in both sectors.
- Difficulty in securing adequate funding for scaling operations and product development.
- Regulatory changes in healthcare or transportation that could impact platform operations.
- Challenges in attracting and retaining skilled talent required for advanced software development and market expansion.
What Are CLTS's Competitive Advantages?
- Dual Market Specialization: Operates in both transportation software and digital health, potentially creating unique cross-segment insights or synergies.
- Specialized Digital Platform: Focus on "specialized" online ordering and "matching" users with offline health services suggests a targeted approach.
- Early-Mover Advantage (Potential): If its specific niche within these markets is unique, it could establish a foothold before larger competitors.
What Does CLTS Do?
Earth Life Sciences Inc. is a technology company with a dual operational focus, headquartered in Reno, Nevada, and primarily serving the North American market. The company is actively involved in the transportation software sector, where it develops and manages solutions aimed at enhancing efficiency and connectivity within logistics and mobility ecosystems. While specific product details are not publicly disclosed, this segment typically encompasses areas such as fleet management, route optimization, supply chain visibility, and data analytics for transportation providers. Complementing its involvement in transportation software, Earth Life Sciences Inc. also operates a specialized digital platform. This platform is designed to facilitate online ordering processes and, critically, to connect users with appropriate offline health services. This suggests a model that could involve appointment scheduling, service booking, or referral systems within the healthcare landscape, leveraging digital access to streamline the patient journey to physical care providers. The company's business activities are concentrated across North America, indicating a strategic focus on this significant and diverse market. With its corporate base in Reno, Earth Life Sciences Inc. maintains a lean operational structure, as evidenced by its reported single employee. This structure suggests a highly focused approach, potentially leveraging external contractors, automated systems, or a foundational development stage for its technology offerings. The company's evolution appears to be centered on identifying and addressing specific needs within both the transportation and digital health sectors through technology-driven solutions.
What Products and Services Does CLTS Offer?
- Develops and manages software solutions for the transportation sector, focusing on logistics and mobility.
- Operates a specialized digital platform designed to facilitate online ordering processes.
- Connects users of its digital platform with appropriate offline health services.
- Aims to enhance efficiency and connectivity within the transportation industry.
- Seeks to streamline access to healthcare services through its digital platform.
- Primarily conducts business operations across the North American market.
- Headquartered in Reno, Nevada.
How Does CLTS Make Money?
- Software Licensing/Subscription: Potentially generates revenue from its transportation software through licensing agreements or recurring subscription fees for businesses.
- Transaction Fees: May earn fees from online orders processed through its digital platform or from successful connections made to offline health services.
- Service Fees: Could charge fees to healthcare providers for lead generation or listing services on its specialized digital health platform.
What Industry Does CLTS Operate In?
Earth Life Sciences Inc. operates within two dynamic and expanding sectors: Information Technology Services, specifically transportation software, and the broader digital health market. The transportation software industry is characterized by a continuous drive for efficiency, automation, and data-driven decision-making in logistics, fleet management, and supply chain operations. Global market projections for transportation management systems often indicate significant growth, driven by e-commerce expansion, urbanization, and the increasing complexity of global supply chains. Concurrently, the digital health services market is experiencing rapid acceleration, fueled by technological advancements, changing consumer preferences for convenience, and the integration of online platforms with traditional healthcare. This segment includes online ordering for health-related products or services and platforms that facilitate access to offline medical care. Earth Life Sciences Inc. positions itself as a participant in both these areas, aiming to leverage technology to address specific needs. The competitive landscape in both sectors is fragmented, with numerous established players and emerging startups. Earth Life Sciences Inc.'s dual focus allows it to potentially create unique synergies, though it also necessitates navigating distinct competitive pressures in each market.
Who Are CLTS's Key Customers?
- Transportation & Logistics Companies: Businesses seeking software solutions for fleet management, route optimization, or supply chain efficiency.
- Individual Consumers: Users seeking convenient online ordering and access to offline health services.
- Healthcare Providers: Clinics, hospitals, or individual practitioners looking to connect with new patients or streamline appointment booking.
Company Profile
Earth Life Sciences Inc. operates in the Information Technology Services industry within the Technology sector. It is headquartered in Reno, US. The company is led by CEO Angelo Marino. CLTS has traded publicly since 2003.
Earth Life Sciences Inc. (CLTS) Valuation Context
Valued at 100K, CLTS is classified as a micro-cap stock. Relative to its peer group, CLTS's quantitative score of 48/100 is below the peer average of 61/100.
ROE -82%Key Financial Metrics
Return on equity for Earth Life Sciences Inc. stands at -82.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -35.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -15.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 2/9Financial Health
Earth Life Sciences Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -6.28 places it in the distress zone, a signal of elevated financial risk.
CLTS Financials
Bull Case vs Bear Case
Bull Case
- Involvement in two high-growth sectors: transportation software and digital health.
- Specialized digital platform for online ordering and health service matching.
- Lean operational structure, potentially allowing for agility and low overhead.
- North American market focus, a large and technologically advanced region.
Bear Case
- Extremely small operational scale with only 1 employee.
- 100K market capitalization, indicating minimal market presence or early development stage.
- Unknown disclosure status on the OTC market, limiting transparency for investors.
- High beta of -55.88, suggesting extreme volatility or illiquidity.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
CLTS Latest News
No recent news available for CLTS.
CLTS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CLTS.
Price Targets
Wall Street price target analysis for CLTS.
CLTS MoonshotScore
What does this score mean?
The MoonshotScore rates CLTS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Angelo Marino
Chief Executive Officer
Angelo Marino serves as the Chief Executive Officer of Earth Life Sciences Inc., overseeing the company's strategic direction and day-to-day operations. His role involves managing the company's lean structure, which currently comprises one employee. While specific details of his prior career history and educational background are not provided, his leadership position at Earth Life Sciences Inc. suggests a background in technology, software development, or entrepreneurial ventures, likely with experience in navigating the early stages of business development within the technology sector. His focus would be on guiding the company's dual initiatives in transportation software and digital health services.
Track Record: Under Angelo Marino's leadership, Earth Life Sciences Inc. has established its presence in both the transportation software and digital health sectors, developing a specialized digital platform. His tenure has been marked by the initiation of these dual business operations and the strategic decision to focus primarily on the North American market. As the sole reported employee, his track record encompasses the foundational development and operational management of the company's technology offerings.
CLTS OTC Market Information
Earth Life Sciences Inc. trades on the OTC market under the "OTC Other" tier. This classification signifies that the company does not meet the reporting standards for OTCQX or OTCQB, which are higher tiers requiring more stringent financial disclosures and compliance. Companies in the "OTC Other" tier, sometimes referred to as the Pink Sheets, typically provide limited or no public information to investors. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to strict listing requirements including minimum share prices, market capitalization, and regular SEC filings, "OTC Other" companies have significantly fewer obligations, leading to reduced transparency and increased investor risk.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Disclosure: Unknown disclosure status means investors lack critical financial and operational information.
- Extreme Illiquidity: 100K market cap and potential low trading volume make it difficult to buy or sell shares.
- High Volatility: The reported Beta of -55.88 suggests unpredictable and potentially extreme price fluctuations.
- Lack of Regulatory Oversight: "OTC Other" tier has minimal reporting requirements compared to major exchanges.
- Fraud Risk: Reduced transparency can increase the potential for fraudulent activities or misrepresentation.
- Verify any available financial statements directly from the company or third-party sources.
- Research the background and legitimacy of Angelo Marino and any other key personnel.
- Investigate any past or ongoing legal or regulatory actions against the company or its leadership.
- Seek independent verification of the company's claimed business operations and technology.
- Understand the company's capital structure, outstanding shares, and any dilution risks.
- Assess the actual market demand and competitive landscape for its specific products/services.
- Evaluate the company's ability to generate revenue and achieve profitability given its scale.
- Clear and consistent business description across multiple sources (though limited here).
- Identified CEO, Angelo Marino, providing a point of contact for leadership.
- Stated physical headquarters in Reno, Nevada.
- Defined operational focus in specific technology sectors (transportation software, digital health).
- Active involvement in two distinct, growing market segments.
CLTS Technology Stock FAQ
How does Earth Life Sciences Inc. generate revenue from its technology products and services?
Earth Life Sciences Inc. operates with a dual revenue potential stemming from its involvement in transportation software and its specialized digital health platform. In the transportation software segment, revenue could be generated through various models, including software licensing fees, recurring subscription services for businesses utilizing its solutions for fleet management or logistics optimization, and potentially through maintenance and support contracts. For its digital platform facilitating online ordering and connecting users with offline health services, revenue streams could include transaction fees for each successful order or service match, referral fees from healthcare providers listed on the platform, or premium subscription tiers for users seeking enhanced features. The precise mix of these revenue streams would depend on the specific implementation and market adoption of its offerings.
What is the operational structure of Earth Life Sciences Inc. given its reported single employee?
Earth Life Sciences Inc. operates with an exceptionally lean structure, reporting only one employee, Angelo Marino, who serves as the Chief Executive Officer. This indicates a highly focused and potentially early-stage operational model. Such a structure suggests that the company likely relies heavily on external resources, such as contract developers, consultants, or outsourced service providers, to manage its dual business segments in transportation software and digital health. It also implies a significant degree of automation in its platform operations or that its current activities are primarily centered on strategic development, intellectual property creation, and foundational market positioning rather than large-scale operational deployment. This lean approach allows for agility but also presents challenges in scaling rapidly without significant capital infusion and team expansion.
What are the primary market opportunities Earth Life Sciences Inc. is targeting with its dual business model?
Earth Life Sciences Inc. is strategically targeting two distinct, yet high-growth, market opportunities through its dual business model. Firstly, in the transportation software sector, it aims to capitalize on the increasing demand for efficient logistics, fleet management, and supply chain optimization solutions across North America. This market is driven by e-commerce expansion and the need for data-driven decision-making in mobility. Secondly, the company is addressing the rapidly expanding digital health market with its specialized platform for online ordering and connecting users with offline health services. This segment benefits from consumer preferences for convenience, digital access to healthcare, and the ongoing integration of technology into patient journeys. By participating in both, Earth Life Sciences Inc. seeks to leverage the broad trends of digitization and service optimization in critical economic sectors.
What are the implications of Earth Life Sciences Inc. trading on the OTC market, specifically the "OTC Other" tier?
Trading on the "OTC Other" tier of the OTC market carries several significant implications for Earth Life Sciences Inc. and its investors. This tier has minimal regulatory oversight and disclosure requirements compared to major exchanges like NASDAQ or NYSE, or even higher OTC tiers. The company's "Unknown" disclosure status means investors may lack access to vital financial statements, operational reports, or governance information, making comprehensive due diligence challenging. Furthermore, the 100K market capitalization and likely low trading volume contribute to extreme illiquidity, resulting in wide bid-ask spreads and difficulty in executing trades. This environment often leads to high price volatility, as reflected in its Beta of -55.88, and increases overall investment risk due to reduced transparency and market efficiency.
How does Earth Life Sciences Inc. differentiate its specialized digital health platform in a competitive market?
Earth Life Sciences Inc. aims to differentiate its digital health platform through its specialized focus on facilitating online ordering and, critically, connecting users with appropriate offline health services. This specific "matching" capability suggests a value proposition centered on streamlining access to physical healthcare, rather than solely focusing on telehealth or general health information. In a crowded digital health market, this specialization could allow the company to carve out a niche by addressing a specific pain point: efficiently bridging the gap between digital discovery and physical service delivery. The platform's "specialized" nature implies a tailored approach, potentially offering a more curated or effective matching process than broader, more generic platforms, thereby enhancing user experience and provider satisfaction within its North American operational scope.
What are the key factors to evaluate for CLTS?
Earth Life Sciences Inc. (CLTS) holds an AI score of 48/100 (low). Not financial advice.
How frequently does CLTS data refresh on this page?
CLTS prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CLTS's recent stock price performance?
Earth Life Sciences Inc. (CLTS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Involvement in two high-growth sectors: transportation software and digital health. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.